Kailera Therapeutics Inc
KLRA
NASDAQ
Biotechnology
$17.94
USD
-0.03 (-0.17%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.46B
Volume 336.0K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 20.3 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 121.4 |
Operating Income | -121.4 |
EBITDA | -121.3 |
Other Income / Expense | 0.1 |
Total Other Income / Expense | 10.1 |
Income Before Income Taxes | -111.3 |
Income Taxes | 0.0 |
Net Income | -111.3 |
Consolidated Net Income / Loss | -111.3 |
Net Income Attributable to Common Shareholders | -111.3 |
Basic EPS | -$1.09 |
Diluted EPS | -$1.09 |
Basic Shares Outstanding | 102.2M |
Diluted Shares Outstanding | 102.2M |